Atlas Trials

Two Regimens of SAR240550/Weekly Paclitaxel and Paclitaxel Alone as Neoadjuvant Therapy in Triple Negative Breast Cancer Patients

Clinical trial NCT01204125 · COMPLETED

Trial details

NCT number
NCT01204125
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer Female
Start date
2010-09-01
Primary completion
2012-10-01
Enrollment
141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.